# Mexidol® Efficacy and Safety in Treatment of VCIND in Older Adults

> **NCT07700615** · PHASE4 · COMPLETED · sponsor: **Pharmasoft** · enrollment: 120 (actual)

## Conditions studied

- Vascular Cognitive Impairment no Dementia

## Interventions

- **DRUG:** Mexidol
- **OTHER:** Standard Therapy

## Key facts

- **NCT ID:** NCT07700615
- **Lead sponsor:** Pharmasoft
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-14
- **Primary completion:** 2025-11-05
- **Final completion:** 2025-11-05
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07700615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07700615, "Mexidol® Efficacy and Safety in Treatment of VCIND in Older Adults". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07700615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*